White J C, Hines L H, Rathmell J P
Cancer Res. 1985 Jul;45(7):3070-5.
The interactions of the epipodophyllotoxins, teniposide (VM-26) and etoposide (VP-16), with the nucleoside carrier were examined with emphasis on their effects on 1-beta-D-arabinofuranosylcytosine (ara-C) transport and net accumulation. VM-26 inhibited ara-C transport by Ehrlich ascites cells within 1 min of exposure, and inhibition was only partially reversed after 45 min in VM-26-free medium. ara-C transport was slowed by 50% by 7 microM VM-26 or by 35 microM VP-16. Since epipodophyllotoxins were noncompetitive inhibitors, fractional inhibition was independent of the ara-C concentration. Analysis of ara-C transport kinetics revealed only a single saturable transport route, and there was no indication of VM-26-insensitive transport. VM-26, VP-16, and ara-C were competitive inhibitors of the specific binding of nitrobenzylthioinosine to the nucleoside carrier with Ki values of 7.4 microM, 23 microM, and 2.2 microM, respectively. The rate of dissociation of nitrobenzylthioinosine (t 1/2 = 20.6 min) was accelerated by 5 microM ara-C (t 1/2 = 18.5 min) but slowed by 100 microM VM-26 (t 1/2 = 34.6). By these criteria, the interaction of VM-26 with the nucleoside carrier was qualitatively similar to that of dipyridamole. Although VM-26 inhibited ara-C transport, it did not significantly slow the rate of net intracellular accumulation of ara-C by Ehrlich cells, presumably because transport capacity far exceeds the capacity for phosphorylation in these cells. In freshly isolated human leukemic blasts, which have far less nucleoside transport activity, inhibition of ara-C accumulation by VM-26 was dependent on the ara-C concentration. At 1 microM ara-C, a concentration where transport was rate limiting for net uptake, VM-26 inhibited accumulation of ara-C over a 60-min time course. At 50 microM ara-C, transport was in excess, and VM-26 did not slow ara-C metabolism.
研究了表鬼臼毒素替尼泊苷(VM - 26)和依托泊苷(VP - 16)与核苷载体的相互作用,重点关注它们对1 - β - D - 阿拉伯呋喃糖基胞嘧啶(ara - C)转运和净积累的影响。VM - 26在暴露于艾氏腹水细胞1分钟内即可抑制ara - C转运,且在无VM - 26的培养基中孵育45分钟后,抑制作用仅部分逆转。7微摩尔VM - 26或35微摩尔VP - 16可使ara - C转运速度减慢50%。由于表鬼臼毒素是非竞争性抑制剂,抑制分数与ara - C浓度无关。ara - C转运动力学分析仅揭示了一条单一的可饱和转运途径,且未显示出对VM - 26不敏感的转运。VM - 26、VP - 16和ara - C是硝基苄硫基肌苷与核苷载体特异性结合的竞争性抑制剂,其Ki值分别为7.4微摩尔、23微摩尔和2.2微摩尔。5微摩尔ara - C可加速硝基苄硫基肌苷的解离速率(t1/2 = 18.5分钟),而100微摩尔VM - 26则使其减慢(t1/2 = 34.6分钟)。根据这些标准,VM - 26与核苷载体的相互作用在性质上与双嘧达莫相似。尽管VM - 26抑制了ara - C转运,但它并未显著减慢艾氏细胞内ara - C的净积累速率,推测是因为这些细胞中的转运能力远远超过磷酸化能力。在新鲜分离的人白血病原始细胞中,其核苷转运活性远低于艾氏细胞,VM - 26对ara - C积累的抑制作用取决于ara - C浓度。在1微摩尔ara - C时,此浓度下转运是净摄取的限速因素,VM - 26在60分钟的时间进程中抑制了ara - C的积累。在50微摩尔ara - C时,转运过量,VM - 26并未减慢ara - C的代谢。